top of page
NM.jpg

IN THE STATES

NEW MEXICO

The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs, economic impact and clinical trial data for the industry as a whole, and vendor/supplier data from 15 major biopharmaceutical companies regarding their business relationships and total expenditures paid to vendors in New Mexico in 2022.

NM.png

Economic
Output

$2.7B

Direct Jobs Supported by the Industry

2,745

Total Jobs Supported

8,579

State Total Vendor Relationships

87

State Total Vendor Spending

$18,515,283

Clinical
Trials

232

Investments at Clinical Trial Sites

$53.4M

Clinical Trial Participants

3,536

Total Economic Impact of Clinical Trial Sites

$126M

bottom of page